Market Overview

Impax Labs Enters Commercialization Deal with Perrigo

Related PRGO
Worst Performing Industries For November 25, 2016
Top Performing Industries For November 23, 2016
Related IPXL
Mid-Afternoon Market Update: Dow Climbs 250 Points; Impax Labs Shares Down Following Q3 Results
20 Biggest Mid-Day Losers For Wednesday

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company (NASDAQ: PRGO;TASE) on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.

Posted-In: News


Related Articles (IPXL + PRGO)

View Comments and Join the Discussion!